Publications
DAVID F. MOBLEY, M.D.
(Download Publications)
1. David F. Mobley and J. Martinez: Two Histologically
Different Primary Carcinomas of the Lung. Cancer 22:287, 1968.
2. David F. Mobley: Case report: Hafnia Septicemia.
Southern Medical Journal,64:505, 1971.
3. David F. Mobley: Familial Vesicoureteral
Reflux. Urology, 2:514, 1973.
4. David
F. Mobley: Left Spermatic Vein Cortisol in Subfertile Men with
Varicocele. Urology, 3:461, 1974.
5. David F. Mobley: Chronic Prostatitis. Southern
Medical Journal, 7:219,1974.
6. David F. Mobley: Erythromycin plus Sodium
Bicarbonate in Chronic Bacterial Prostatitis. Urology 3:60,
1974.
7. David F. Mobley and Donald P. Griffith: Acute
Urinary Retention in a Child Due to Pyocolpos and Pyometrium.
Urology, 3:784,1974.
8. Neil Baum, David F. Mobley, and C.E. Carlton,
Jr.: Ureteral Replacements. Urology, 5:165, 1975.
9. David F. Mobley: Semen Cultures in the Diagnosis
of Bacterial Prostatitis. Journal of Urology, 114:83, 1975.
10. David F. Mobley: Metastatic Carcinoma of
the Prostate Masquerading as an Abdominal Aortic Aneurysm. Urology,
5:796, 1975.
11. David F. Mobley and Thomas H. Guthrie: Renal
Cell Carcinoma Metastatic to the Urinary Bladder. Urology, 8:53,
1`976.
12. David F. Mobley: Phenoxybenzamine in Neurogenic
Vesical Dysfunction. J. Urol, 116:732,1976.
13. David F. Mobley: Studies in Ureteral Regeneration: Replacement
of a Large Segment of Ureter with an in-situ Pedicle Graft of
Proximal Ureter. Investigative Urology, 14:269, 1977.
14. Taiji Nishimura, David F. Mobley and C.E.
Carlton, Jr.: Clinical Use of Immunoelectrophoresis of Split
Ejaculates. I. Variation of Patterns due to Antisera. Urology,
9:39, 1977.
15. Taiji Nishimura, David F. Mobley and C.E.
Carlton, Jr.: Preliminary Communications: Immunoglobulin-A in
Split-Ejaculations of Patients with Prostatitis. Urology, 9:186,
1977.
16. David F. Mobley and Neil Baum: Renal Vein
Thrombosis in renal Carcinoma; Proteinuria as a Daignostic Sign.
In Progress.
17. David F. Mobley: Bacterial
Prostatitis: Treatment with Carbenicillin Indanyl Sodium. Investigative
Urology. 19:1:31, August 1981.
18. Kostas, C., Mobley,D., Rous,S., Schneider,
R., and Burt, R.: Treatment of Urinary Tract Infections with
Cephalexin. Journal of Family Practice. 17:135, 1983.
19. David F. Mobley, and Avi Raphaeli: Evaluation
and Treatment of Impotence. Physician and Patient. :39, September
1984.
20. David F. Mobley: Choosing a Penile
Prosthesis. Medical Aspects of Human Sexuality. May 1987.
21. David F. Mobley: A New Simplified Techinque
for Implantation of Penile Prosthesis Reservoir. Colleagues
in Urology. Summer Quarter 1988.
22.. David F. Mobley: Penile Prosthesis Malfunction.
Medical Aspects of Human Sexuality. :69:May 1990.
23. David F. Mobley: Pelvic Trauma; Implications
for Fertility and Potency. Accepted for Publication. Medical
Aspects of Human Sexuality. January, 1991.
24. David F. Mobley and Neil Baum: Choosing
a Sex Therapist for Your Pateint. Accepted for Publication.
Medcial Aspects of Human Sexuality. December 1990.
25. David F. Mobley: Penile Curvature: Brief
Communication. Medical Aspects of Human Sexuality. 24:12:13,
1990.
26. David F. Mobley: Sustained Erection. Brief
Communication. Accepted for Publication. Medical Aspects of
Human Sexuality. February 1991.
27. David F. Mobley, Ken Goldberg, and Steve
Wilson: Management of Urinary Incontinence, Part I. Geriatric
Medicine. Vol 10, No.9,Sept 1991.
28. David F. Mobley. Kidney Stones. Health and
Fitness. Vol 7,Number 3, November, 1991.
29. Baum, N.B, Suarez, G., Mobley, D.: Use of
Infrapubic Incision for Insertion
of Mentor Mark II Inflatable Penile Prosthesis. Urology 34:5:436,
May 1992.
30. Mobley, D., Baum, N., and Wilson, S.: Experience
with 333 Cases of Mentor Alpha One Penile Prostheses.
Urology, 42:3:305, September 1993.
31. Gillenwater, J.y., Fawzy, A., Klimberg, I. Mobley, D.F.
Conn, R.L., Roy. J.:
Doxazosin for the Treatment of BPH in Patients with Mild to
Moderate
Essential Hypertension.
Submitted for Publication: Journal of Urology, May, 1994
32. Mobley, D. Lepor, H.: Effects of doxazosin
on the symptoms of benign
prostatic hyperplasia: Results from three double blind, placebo
controlled
studies.
Submitted for Publication. J. Urol Oct. 1994
33. Mobley, D.,McConnell, J., Fisher, H, Milam,
D.: The Effect of Zanoterone, A Steroidal Androgen Recetor Antagonist
in Men with Benign Prostatic
Hyperplasia.
Accepted for Publication by J. Urology, February 1995.
34. Mobley, D.F. and Baum, N.H.: Interstitial
Cystitis.
Postgraduate Medicine 95:201May, 1996
35. Lepor, H., Kaplan, S., Mobley, D.F., et.
al.
Doxazosin in benign prostatic hyperplasia: long-term efficacy
and safety
in hypertensive and normotensive patients. J. Urology 157,125
Jan 97
36. Mobley, D.F., Kaplan, S.: Effect of Doxazosin
on the Symptoms of Benign
Prostatic Hyperplasia. Submitted for publication; American J.
of Medicine
37. Mobley, D.F., Baum, N.B.: Operate or Medicate-The
Pharmacoeconomics
of BPH. Approved for Publication, Contemporary Urology. Oct
1996
38. Mobley, D.F., Dias,
N., and Levenstein, M.: Doxazosin in patients
with Benign Prostatic Hyperplasia: Effects as a Function of
Baseline
severity. Submitted to Clinical therapeutics. October 1997
39. McConnell, John (Mobley,
D.F.) et. al. The Long-Term Effects of Finasteride on BPH: Results
of a Four-Year, Placebo-Controlled
Study. Submitted for Publikcation., NEJM, October 1997
40. Mobley, D.F., and Baum, N.H.: Management
of Impotence in the Geriatric Man Accepted for Publication.
Clinical Geriatrics. October 1997
41. Brown, J., Mobley, D. F., et. al.: Efficacy
and Tolerability of Once-Daily
Oxybutyinin Chloride versus Ditropan in Patients with Urge or
Mixed
Urinary Incontinence. Abstract Submitted to AUA, October 1997
42. Mobley, D.F., Baum, N.H.: When Patients
Request the Pill. Postgraduate
Medicine. 104/No. 2/August 1998.
43. Anderson, R., Mobley, D.F., et. al.: Comparative
Efficacy and Safety of a
Once-a-Day Controlled Release and an Immediate Release Oxybutyinin
Chloride in the Treatment of Patients With Urge Urinary Incontinence.
Submitted to Journal of Urology. October 1998.
44. Mobley, D.F., and Baum, N.H.: Management
of Impotence in the Geriatric
Man. Clinical Geriatrics. 6:9 58, August, 1998
45. Mobley, D.F. and Baum, N.: Office Evaluation
of the Impotent Man.
Journal of the Vietnamese Physician-Dentist and Pharmacist
Assn. Of Louisiana. 26: Fall, 1998
46. Mobley, D.F., Baum, N.H.: Kidney Stones-Medical
Management and When to Refer. Hospital Medicine
47. Mobley, D.F., Baum, N.H.: Viagra and the Oral therapies
for Impotence.
Accepted for publication. Hospital Medicine. Jan 1999
48. Roerhborn,C.G. Boyle, P (Mobley,D.F.) et.
al.: Serum Prostate-Specific antigen and prostate volume predict
long-term changes in sypmtoms and flow rate: Results of a four-year,
randomized trial comparing finasteride versus placebo. Submitted
to Urology. December 1998
49. Kaplan, S., Garvin, D. (Mobley, D.F.) et.
al: The impact of baseline symptom severity on future risk of
BPH-related outcomes and long-term response to finasteride.
Submitted to Urology. Dec. 1998
50. Rillard, R., Tuttle, J., Moore, K. (Mobley,
D.F.): Clinical Efficacy and Safety of Tolterodine Compared
to Placebo in Detrusor Overactivity.
J. Urol 161:5:1551, May 1998
51. Mobley, D.F., and Baum, N.H.: Management
of Impotence in the Geriatric Man
Accepted for Publication. Clinical Geriatrics. October 1997
52. Mobley, D.F., Baum, N.H.: Viagra and the Oral therapies
for Impotence.
Accepted for publication. Hospital Medicine. Jan 1999
53. Mobley, D.F., Baum, N.B.: Caveats on Viagra-It’s
Not Candy.
Journal of the Vietnamese Physician-Dentist & Pharmacist
Association of
Louisiana. Spring 1999
54. Anderson, R.U., Moble y, D.F., Blank, B.
et. al.: Once Daily Controlled Versus Immediate Release Oxybutynin
Chloride for Urge Urinary Incontinence.
J. Urology 181:1809: June 1999
55. Versi, Eboo, Appell, R Mobley, David et.
al.: Comparison of Dry Mouth With Conventional and Controlled-Release
Oxybutinin in Urinary Incontinence. Ob/Gyn95:718-721 2000
56. Roehrborn, C.G, Boyle, P (Mobley, D.F.,)
et. al. Serum Prostate-Specific Antigen and Prostate Volume
Predict Long-Term Changes in Symptoms
And Flow Rate: Results of a Four-Year Randomized Trial Comparing
Finasteride to Placebo. Urology 54(4)662. Oct. 1999.
57. Bruskewitz, R, Girman, C (Mobley, D.F.)
et. al.: Effect of Finasteride on Bother and Other Health-Related
Quality of Life Aspects Associated with Benign Prostatic Hyperplasia.
Urology 54 (4) 670, Oct 1999
58. Mobley, D.F., Baum, N.H.: Management of
Sexually Transmitted Diseases in Diabetic Men. Diabetes Educator.
February 2000
59. Dula, E, (Mobley,D.)
Keating, W. et. al.: Efficacy and Safety of Fixed-Dose and Dose-Optimization
Regimens of Sublingual Apomorphine in Men
With Erectile Dysfunction. Urology 56:130, 2000
60. Mobley, D.F. et. Al.: Effects of Doxazosin
in Patients with Mild, Intermediate and Severe Benign Prostatic
Hyperplasia. Clinical therapeutics: 20:1 101-109 January 1998
61. Kaplan,S, Holtgrew,L.,Bruskewitz,R.,Mobley,D.F.
Comparison of the Efficacy and Safety of Finasteride in Older
Versus Younger Men With Benign Prostatic Hyperplasia. Urology.
57:1073, June 2001
62. Matsumuto, A.M., Tenover,L., Mobley, D.F.
et al.: The Long-Term Effect of Specific Type II 5-a Reductase
Inhibition with Finasteride on Bone Mineral Density in Men:
Results of a 4-Year, Placebo-Controlled Trial. Presented for
publication to Journal of Urology,. June 2001
63. Roehrobron, C. (Mobley, D) Efficacy and
safety of Once-Daily Alfuzosin in the Treatment of Lower Urinary
Tract Symptomsnand Clinical Benign Prostatic Hyperplasia: A
Randomized, Placebo-Controlled Trial. Urology;58 (6) 953 December
2001
64. Matsumoto, A, Tenover, L., McClung, M.,
Mobley, D. The Long-Term Effect of Specific Type II 5-alpha
Reductase Inhibition with Finasteride on Bone Mineral Density
in Men: Results of a 4-year Placebo Controlled Trial; J. Urolgoy
167;2105-2108. May 2002
65. Mobley, D., Baum, N: Treatment of Hot Flashes
in men being treated with hormone therapy for prostate cancer.
Geriatrics. Accepted. Feb 2003
66. Mobley, D., Baum, N.: Management of Benign
Prostatic Hyperplasia in the elderly patient. Geriatrics. Accepted
April 2003
67. Mobley, D.F., Prostate Cancer.Houston Medical
Journal; 1;vol 9, p.3, November 2003
BOOKS:
David F. Mobley and Steven K. Wilson: Impotence,
It's Reversible.
Southwest Impotency Center. 1990.
Mobley, D.F. and Wilson, Steven K.: Reversing
Impotence Forever
Swan Publishing Co. Houston 1995
TAPES:
Mobley, D. McMurray, James, Mulcahy, J: Helping
Your Impotent
Patients Make a Treatment Decision: Produced by American Medical
Systems. 1989.
Mobley, D., Baum, N., Gottesman, J.: Roundtable
Forum on Practice
Management: Prepared by American Medical Systems, 1993.
1. Patient Relations
2. Physician and Community Relations
3. Managing the Business Side of a Urology Practice
Mobley, D., Baum, N., Eid, F ; A Primer on
Marketing Your Practice
Produced by American Medical Systems. April 1997
TEXTBOOK CHAPTER:
Mobley, D.F., and Baum, N.H.: Office Evaluation
of the Impotent Man.
IN: Textbook Of Andrology, W.J.G. Hellstrom, editor
Verlag-Springer New York .1997
BROCHURE:
Mobley, D.F., Feinstein, C., Garber, B.: et.
al. Building your Impotence Practice Through Medical Marketing.
American Medical Systems 1997
ABSTRACTS:
Appell, R, Mobley, D.F. et. al.: Comparison
of Urge Incontinence Treatments.
Submitted for presentation at 1999 AUA annual meeting.
Appell, R., Mobley, D.F. et. al. Factors Influencing
patient Response to
Controlled-Release Oxybutinin: A Meta-Analysis of Randomized
Trials. Submitted for presentation at 1999 AUA annual meeting.
Anderson, R., Gittleman, M. Mobley, D.F. et.
al. The Effect of Age on
Efficacy, Safety and Tolerability of Once-Daily Oxybutyine Chloride.
Submitted for presentation at 1999 AUA annual meeting.
WORKS IN PROGRESS:
Incontinence: It is Treatable: Book in collaboration with Neil
Baum, M.D. In Progress.
